Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibodies in Oncology Market Size by Type: 2016 VS 2021 VS 2027
1.2.2 Murine Antibodies
1.2.3 Chimeric and Humanised Antibodies
1.2.4 Fully Humanized Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibodies in Oncology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Academic Institutes
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trend
2.1 Global Antibodies in Oncology Market Perspective (2016-2027)
2.2 Global Antibodies in Oncology Growth Trends by Regions
2.2.1 Antibodies in Oncology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antibodies in Oncology Historic Market Size by Regions (2016-2021)
2.2.3 Antibodies in Oncology Forecasted Market Size by Regions (2022-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Antibodies in Oncology Industry Trends
2.3.2 Antibodies in Oncology Market Drivers
2.3.3 Antibodies in Oncology Market Challenges
2.3.4 Antibodies in Oncology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antibodies in Oncology Players by Market Size
3.1.1 Players Covered: Ranking by Antibodies in Oncology Revenue
3.1.2 Global Top Antibodies in Oncology Players by Revenue (2016-2021)
3.1.3 Global Antibodies in Oncology Revenue Market Share by Players (2016-2021)
3.1.4 Global Antibodies in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antibodies in Oncology Market Concentration Ratio
3.2.1 Global Antibodies in Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 5 and Top 10 Players by Antibodies in Oncology Revenue in 2020
3.3 Antibodies in Oncology Key Players Head office and Area Served
3.4 Key Players Antibodies in Oncology Product Solution and Service
3.5 Date of Enter into Antibodies in Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Global Antibodies in Oncology Breakdown Data by Type (2016-2027)
4.1 Global Antibodies in Oncology Historic Market Size by Type (2016-2021)
4.2 Global Antibodies in Oncology Forecasted Market Size by Type (2022-2027)

5 Global Antibodies in Oncology Breakdown Data by Application (2016-2027)
5.1 Global Antibodies in Oncology Historic Market Size by Application (2016-2021)
5.2 Antibodies in Oncology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antibodies in Oncology Market Size (2016-2027)
6.2 Key Antibodies in Oncology Players Market Share in North America (2020-2021)
6.3 North America Antibodies in Oncology Market Size by Country
6.3.1 North America Antibodies in Oncology Sales by Country (2016-2021)
6.3.2 North America Antibodies in Oncology Market Size Forecast by Country (2022-2027)
6.4 U.S. Market Size Analysis
6.4.1 U.S. Antibodies in Oncology Market Size (2016-2027)
6.4.2 U.S. Antibodies in Oncology Market Size by Type (2016-2027)
6.4.3 U.S. Antibodies in Oncology Market Size by Application (2016-2027)
6.5 Canada Market Size Analysis
6.5.1 Canada Antibodies in Oncology Market Size (2016-2027)
6.5.2 Canada Antibodies in Oncology Market Size by Type (2016-2027)
6.5.3 Canada Antibodies in Oncology Market Size by Application (2016-2027)
7 Europe
7.1 Europe Antibodies in Oncology Market Size (2016-2027)
7.2 Key Antibodies in Oncology Players Market Share in Europe (2020-2021)
7.3 Europe Antibodies in Oncology Market Size by Country
7.3.1 Europe Antibodies in Oncology Sales by Country (2016-2021)
7.3.2 Europe Antibodies in Oncology Market Size Forecast by Country (2022-2027)
7.4 Germany Market Size Analysis
7.4.1 Germany Antibodies in Oncology Market Size (2016-2027)
7.4.2 Germany Antibodies in Oncology Market Size by Type (2016-2027)
7.4.3 Germany Antibodies in Oncology Market Size by Application (2016-2027)
7.5 France Market Size Analysis
7.5.1 France Antibodies in Oncology Market Size (2016-2027)
7.5.2 France Antibodies in Oncology Market Size by Type (2016-2027)
7.5.3 France Antibodies in Oncology Market Size by Application (2016-2027)
7.6 U.K. Market Size Analysis
7.6.1 U.K. Antibodies in Oncology Market Size (2016-2027)
7.6.2 U.K. Antibodies in Oncology Market Size by Type (2016-2027)
7.6.3 U.K. Antibodies in Oncology Market Size by Application (2016-2027)
7.7 Italy Market Size Analysis
7.7.1 Italy Antibodies in Oncology Market Size (2016-2027)
7.7.2 Italy Antibodies in Oncology Market Size by Type (2016-2027)
7.7.3 Italy Antibodies in Oncology Market Size by Application (2016-2027)
7.8 Russia Market Size Analysis
7.8.1 Russia Antibodies in Oncology Market Size (2016-2027)
7.8.2 Russia Antibodies in Oncology Market Size by Type (2016-2027)
7.8.3 Russia Antibodies in Oncology Market Size by Application (2016-2027)
8 Asia-Pacific
8.1 Asia-Pacific Antibodies in Oncology Market Size (2016-2027)
8.2 Key Antibodies in Oncology Players Market Share in Asia-Pacific (2020-2021)
8.3 Asia-Pacific Antibodies in Oncology Market Size by Region
8.3.1 Asia-Pacific Antibodies in Oncology Sales by Region (2016-2021)
8.3.2 Asia-Pacific Antibodies in Oncology Market Size Forecast by Region (2022-2027)
8.4 China Market Size Analysis
8.4.1 China Antibodies in Oncology Market Size (2016-2027)
8.4.2 China Antibodies in Oncology Market Size by Type (2016-2027)
8.4.3 China Antibodies in Oncology Market Size by Application (2016-2027)
8.5 Japan Market Size Analysis
8.5.1 Japan Antibodies in Oncology Market Size (2016-2027)
8.5.2 Japan Antibodies in Oncology Market Size by Type (2016-2027)
8.5.3 Japan Antibodies in Oncology Market Size by Application (2016-2027)
8.6 South Korea Market Size Analysis
8.6.1 South Korea Antibodies in Oncology Market Size (2016-2027)
8.6.2 South Korea Antibodies in Oncology Market Size by Type (2016-2027)
8.6.3 South Korea Antibodies in Oncology Market Size by Application (2016-2027)
8.7 India Market Size Analysis
8.7.1 India Antibodies in Oncology Market Size (2016-2027)
8.7.2 India Antibodies in Oncology Market Size by Type (2016-2027)
8.7.3 India Antibodies in Oncology Market Size by Application (2016-2027)
8.8 Australia Market Size Analysis
8.8.1 Australia Antibodies in Oncology Market Size (2016-2027)
8.8.2 Australia Antibodies in Oncology Market Size by Type (2016-2027)
8.8.3 Australia Antibodies in Oncology Market Size by Application (2016-2027)
8.9 Taiwan Market Size Analysis
8.9.1 Taiwan Antibodies in Oncology Market Size (2016-2027)
8.9.2 Taiwan Antibodies in Oncology Market Size by Type (2016-2027)
8.9.3 Taiwan Antibodies in Oncology Market Size by Application (2016-2027)
8.10 Indonesia Market Size Analysis
8.10.1 Indonesia Antibodies in Oncology Market Size (2016-2027)
8.10.2 Indonesia Antibodies in Oncology Market Size by Type (2016-2027)
8.10.3 Indonesia Antibodies in Oncology Market Size by Application (2016-2027)
8.11 Thailand Market Size Analysis
8.11.1 Thailand Antibodies in Oncology Market Size (2016-2027)
8.11.2 Thailand Antibodies in Oncology Market Size by Type (2016-2027)
8.11.3 Thailand Antibodies in Oncology Market Size by Application (2016-2027)
8.12 Malaysia Market Size Analysis
8.12.1 Malaysia Antibodies in Oncology Market Size (2016-2027)
8.12.2 Malaysia Antibodies in Oncology Market Size by Type (2016-2027)
8.12.3 Malaysia Antibodies in Oncology Market Size by Application (2016-2027)
8.13 Philippines Market Size Analysis
8.13.1 Philippines Antibodies in Oncology Market Size (2016-2027)
8.13.2 Philippines Antibodies in Oncology Market Size by Type (2016-2027)
8.13.3 Philippines Antibodies in Oncology Market Size by Application (2016-2027)
8.14 Vietnam Market Size Analysis
8.14.1 Vietnam Antibodies in Oncology Market Size (2016-2027)
8.14.2 Vietnam Antibodies in Oncology Market Size by Type (2016-2027)
8.14.3 Vietnam Antibodies in Oncology Market Size by Application (2016-2027)
9 Latin America
9.1 Latin America Antibodies in Oncology Market Size (2016-2027)
9.2 Key Antibodies in Oncology Players Market Share in Latin America (2020-2021)
9.3 Latin America Antibodies in Oncology Market Size by Country
9.3.1 Latin America Antibodies in Oncology Sales by Country (2016-2021)
9.3.2 Latin America Antibodies in Oncology Market Size Forecast by Country (2022-2027)
9.4 Mexico Market Size Analysis
9.4.1 Mexico Antibodies in Oncology Market Size (2016-2027)
9.4.2 Mexico Antibodies in Oncology Market Size by Type (2016-2027)
9.4.3 Mexico Antibodies in Oncology Market Size by Application (2016-2027)
9.5 Brazil Market Size Analysis
9.5.1 Brazil Antibodies in Oncology Market Size (2016-2027)
9.5.2 Brazil Antibodies in Oncology Market Size by Type (2016-2027)
9.5.3 Brazil Antibodies in Oncology Market Size by Application (2016-2027)
9.6 Argentina Market Size Analysis
9.6.1 Argentina Antibodies in Oncology Market Size (2016-2027)
9.6.2 Argentina Antibodies in Oncology Market Size by Type (2016-2027)
9.6.3 Argentina Antibodies in Oncology Market Size by Application (2016-2027)
10 Middle East & Africa
10.1 Middle East & Africa Antibodies in Oncology Market Size (2016-2027)
10.2 Key Antibodies in Oncology Players Market Share in Middle East & Africa (2020-2021)
10.3 Middle East & Africa Antibodies in Oncology Market Size by Country
10.3.1 Middle East & Africa Antibodies in Oncology Sales by Country (2016-2021)
10.3.2 Middle East & Africa Antibodies in Oncology Market Size Forecast by Country (2022-2027)
10.4 Turkey Market Size Analysis
10.4.1 Turkey Antibodies in Oncology Market Size (2016-2027)
10.4.2 Turkey Antibodies in Oncology Market Size by Type (2016-2027)
10.4.3 Turkey Antibodies in Oncology Market Size by Application (2016-2027)
10.5 Saudi Arabia Market Size Analysis
10.5.1 Saudi Arabia Antibodies in Oncology Market Size (2016-2027)
10.5.2 Saudi Arabia Antibodies in Oncology Market Size by Type (2016-2027)
10.5.3 Saudi Arabia Antibodies in Oncology Market Size by Application (2016-2027)
10.6 UAE Market Size Analysis
10.6.1 UAE Antibodies in Oncology Market Size (2016-2027)
10.6.2 UAE Antibodies in Oncology Market Size by Type (2016-2027)
10.6.3 UAE Antibodies in Oncology Market Size by Application (2016-2027)

11 Key Players Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Company Details
11.1.2 Novartis International AG Business Overview and Its Total Revenue
11.1.3 Novartis International AG Antibodies in Oncology Introduction
11.1.4 Novartis International AG Revenue in Antibodies in Oncology Business (2016-2021)
11.1.5 Novartis International AG Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
11.2.3 GlaxoSmithKline plc Antibodies in Oncology Introduction
11.2.4 GlaxoSmithKline plc Revenue in Antibodies in Oncology Business (2016-2021)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Biogen Idec Inc.
11.3.1 Biogen Idec Inc. Company Details
11.3.2 Biogen Idec Inc. Business Overview and Its Total Revenue
11.3.3 Biogen Idec Inc. Antibodies in Oncology Introduction
11.3.4 Biogen Idec Inc. Revenue in Antibodies in Oncology Business (2016-2021)
11.3.5 Biogen Idec Inc. Recent Development
11.4 Bristol Myers Squibb Co.
11.4.1 Bristol Myers Squibb Co. Company Details
11.4.2 Bristol Myers Squibb Co. Business Overview and Its Total Revenue
11.4.3 Bristol Myers Squibb Co. Antibodies in Oncology Introduction
11.4.4 Bristol Myers Squibb Co. Revenue in Antibodies in Oncology Business (2016-2021)
11.4.5 Bristol Myers Squibb Co. Recent Development
11.5 AstraZeneca plc.
11.5.1 AstraZeneca plc. Company Details
11.5.2 AstraZeneca plc. Business Overview and Its Total Revenue
11.5.3 AstraZeneca plc. Antibodies in Oncology Introduction
11.5.4 AstraZeneca plc. Revenue in Antibodies in Oncology Business (2016-2021)
11.5.5 AstraZeneca plc. Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Details
11.6.2 Celltrion Business Overview and Its Total Revenue
11.6.3 Celltrion Antibodies in Oncology Introduction
11.6.4 Celltrion Revenue in Antibodies in Oncology Business (2016-2021)
11.6.5 Celltrion Recent Development
11.7 3SBIO
11.7.1 3SBIO Company Details
11.7.2 3SBIO Business Overview and Its Total Revenue
11.7.3 3SBIO Antibodies in Oncology Introduction
11.7.4 3SBIO Revenue in Antibodies in Oncology Business (2016-2021)
11.7.5 3SBIO Recent Development
11.8 Celgen Biopharma
11.8.1 Celgen Biopharma Company Details
11.8.2 Celgen Biopharma Business Overview and Its Total Revenue
11.8.3 Celgen Biopharma Antibodies in Oncology Introduction
11.8.4 Celgen Biopharma Revenue in Antibodies in Oncology Business (2016-2021)
11.8.5 Celgen Biopharma Recent Development
11.9 Dr Reddy’s
11.9.1 Dr Reddy’s Company Details
11.9.2 Dr Reddy’s Business Overview and Its Total Revenue
11.9.3 Dr Reddy’s Antibodies in Oncology Introduction
11.9.4 Dr Reddy’s Revenue in Antibodies in Oncology Business (2016-2021)
11.9.5 Dr Reddy’s Recent Development

12 Analyst's Viewpoints/Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer

List of Figure

List of Tables
Table 1. Global Antibodies in Oncology Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Key Players of Murine Antibodies
Table 3. Key Players of Chimeric and Humanised Antibodies
Table 4. Key Players of Fully Humanized Antibodies
Table 5. Key Players of Others
Table 6. Global Antibodies in Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antibodies in Oncology Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Antibodies in Oncology Market Size by Regions (2016-2021) (US$ Million)
Table 9. Global Antibodies in Oncology Market Share by Regions (2016-2021)
Table 10. Global Antibodies in Oncology Forecasted Market Size by Regions (2022-2027) (US$ Million)
Table 11. Global Antibodies in Oncology Market Share by Regions (2022-2027)
Table 12. Antibodies in Oncology Market Trends
Table 13. Antibodies in Oncology Market Drivers
Table 14. Antibodies in Oncology Market Challenges
Table 15. Antibodies in Oncology Market Restraints
Table 16. Ranking of Global Top Antibodies in Oncology Manufacturers by Revenue (US$ Million) in 2020
Table 17. Global Antibodies in Oncology Revenue by Players (2016-2021) (US$ Million)
Table 18. Global Antibodies in Oncology Market Share by Players (2016-2021)
Table 19. Global Top Antibodies in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibodies in Oncology as of 2020)
Table 20. Global 5 Largest Players Market Share by Antibodies in Oncology Revenue (CR5 and HHI) (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibodies in Oncology Product Solution and Service
Table 23. Date of Enter into Antibodies in Oncology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibodies in Oncology Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Antibodies in Oncology Revenue Market Share by Type (2016-2021)
Table 27. Global Antibodies in Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Antibodies in Oncology Revenue Market Share by Type (2022-2027)
Table 29. Global Antibodies in Oncology Market Size by Application (2016-2021) (US$ Million)
Table 30. Global Antibodies in Oncology Revenue Market Share by Application (2016-2021)
Table 31. Global Antibodies in Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Antibodies in Oncology Revenue Market Share by Application (2022-2027)
Table 33. Key Players Antibodies in Oncology Revenue in North America (2020-2021) (US$ Million)
Table 34. North America Antibodies in Oncology Market Size by Countries (2016-2021) (US$ Million)
Table 35. North America Antibodies in Oncology Market Size Share by Countries (2016-2021)
Table 36. North America Antibodies in Oncology Market Size by Countries (2022-2027) (US$ Million)
Table 37. North America Antibodies in Oncology Market Size Share by Countries (2022-2027)
Table 38. Antibodies in Oncology Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021)
Table 39. Antibodies in Oncology Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027)
Table 40. Antibodies in Oncology Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021)
Table 41. Antibodies in Oncology Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027)
Table 42. Antibodies in Oncology Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021)
Table 43. Antibodies in Oncology Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027)
Table 44. Antibodies in Oncology Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021)
Table 45. Antibodies in Oncology Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027)
Table 46. Key Players Antibodies in Oncology Revenue in Europe (2020-2021) (US$ Million)
Table 47. Europe Antibodies in Oncology Market Size by Countries (2016-2021) (US$ Million)
Table 48. Europe Antibodies in Oncology Market Size Share by Countries (2016-2021)
Table 49. Europe Antibodies in Oncology Market Size by Countries (2022-2027) (US$ Million)
Table 50. Europe Antibodies in Oncology Market Size Share by Countries (2022-2027)
Table 51. Antibodies in Oncology Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021)
Table 52. Antibodies in Oncology Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027)
Table 53. Antibodies in Oncology Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021)
Table 54. Antibodies in Oncology Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027)
Table 55. Antibodies in Oncology Market Size (US$ Million) in France, Breakdown by Type (2016-2021)
Table 56. Antibodies in Oncology Market Size (US$ Million) in France, Breakdown by Type (2022-2027)
Table 57. Antibodies in Oncology Market Size (US$ Million) in France, Breakdown by Application (2016-2021)
Table 58. Antibodies in Oncology Market Size (US$ Million) in France, Breakdown by Application (2022-2027)
Table 59. Antibodies in Oncology Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021)
Table 60. Antibodies in Oncology Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027)
Table 61. Antibodies in Oncology Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021)
Table 62. Antibodies in Oncology Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027)
Table 63. Antibodies in Oncology Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021)
Table 64. Antibodies in Oncology Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027)
Table 65. Antibodies in Oncology Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021)
Table 66. Antibodies in Oncology Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027)
Table 67. Antibodies in Oncology Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021)
Table 68. Antibodies in Oncology Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027)
Table 69. Antibodies in Oncology Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021)
Table 70. Antibodies in Oncology Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027)
Table 71. Key Players Antibodies in Oncology Revenue in Asia-Pacific (2020-2021) (US$ Million)
Table 72. Asia-Pacific Antibodies in Oncology Market Size by Regions (2016-2021) (US$ Million)
Table 73. Asia-Pacific Antibodies in Oncology Market Size by Regions (2022-2027) (US$ Million)
Table 74. Antibodies in Oncology Market Size (US$ Million) in China, Breakdown by Type (2016-2021)
Table 75. Antibodies in Oncology Market Size (US$ Million) in China, Breakdown by Type (2022-2027)
Table 76. Antibodies in Oncology Market Size (US$ Million) in China, Breakdown by Application (2016-2021)
Table 77. Antibodies in Oncology Market Size (US$ Million) in China, Breakdown by Application (2022-2027)
Table 78. Antibodies in Oncology Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021)
Table 79. Antibodies in Oncology Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027)
Table 80. Antibodies in Oncology Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021)
Table 81. Antibodies in Oncology Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027)
Table 82. Antibodies in Oncology Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021)
Table 83. Antibodies in Oncology Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027)
Table 84. Antibodies in Oncology Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021)
Table 85. Antibodies in Oncology Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027)
Table 86. Antibodies in Oncology Market Size (US$ Million) in India, Breakdown by Type (2016-2021)
Table 87. Antibodies in Oncology Market Size (US$ Million) in India, Breakdown by Type (2022-2027)
Table 88. Antibodies in Oncology Market Size (US$ Million) in India, Breakdown by Application (2016-2021)
Table 89. Antibodies in Oncology Market Size (US$ Million) in India, Breakdown by Application (2022-2027)
Table 90. Antibodies in Oncology Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021)
Table 91. Antibodies in Oncology Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027)
Table 92. Antibodies in Oncology Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021)
Table 93. Antibodies in Oncology Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027)
Table 94. Antibodies in Oncology Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021)
Table 95. Antibodies in Oncology Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027)
Table 96. Antibodies in Oncology Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021)
Table 97. Antibodies in Oncology Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027)
Table 98. Antibodies in Oncology Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021)
Table 99. Antibodies in Oncology Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027)
Table 100. Antibodies in Oncology Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021)
Table 101. Antibodies in Oncology Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027)
Table 102. Key Players Antibodies in Oncology Revenue in Latin America (2020-2021) (US$ Million)
Table 103. Latin America Antibodies in Oncology Market Size by Countries (2016-2021) (US$ Million)
Table 104. Latin America Antibodies in Oncology Market Size by Countries (2022-2027) (US$ Million)
Table 105. Antibodies in Oncology Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021)
Table 106. Antibodies in Oncology Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027)
Table 107. Antibodies in Oncology Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021)
Table 108. Antibodies in Oncology Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027)
Table 109. Antibodies in Oncology Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021)
Table 110. Antibodies in Oncology Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027)
Table 111. Antibodies in Oncology Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021)
Table 112. Antibodies in Oncology Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027)
Table 113. Antibodies in Oncology Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021)
Table 114. Antibodies in Oncology Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027)
Table 115. Antibodies in Oncology Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021)
Table 116. Antibodies in Oncology Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027)
Table 117. Key Players Antibodies in Oncology Revenue in Middle East & Africa (2020-2021) (US$ Million)
Table 118. Middle East & Africa Antibodies in Oncology Market Size by Countries (2016-2021) (US$ Million)
Table 119. Middle East & Africa Antibodies in Oncology Market Size by Countries (2022-2027) (US$ Million)
Table 120. Antibodies in Oncology Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021)
Table 121. Antibodies in Oncology Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027)
Table 122. Antibodies in Oncology Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021)
Table 123. Antibodies in Oncology Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027)
Table 124. Antibodies in Oncology Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021)
Table 125. Antibodies in Oncology Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027)
Table 126. Antibodies in Oncology Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021)
Table 127. Antibodies in Oncology Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027)
Table 128. Antibodies in Oncology Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021)
Table 129. Antibodies in Oncology Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027)
Table 130. Antibodies in Oncology Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021)
Table 131. Antibodies in Oncology Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027)
Table 132. Novartis International AG Company Details
Table 133. Novartis International AG Business Overview
Table 134. Novartis International AG Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 135. Novartis International AG Antibodies in Oncology Antibodies in Oncology Product
Table 136. Novartis International AG Recent Development
Table 137. GlaxoSmithKline plc Company Details
Table 138. GlaxoSmithKline plc Business Overview
Table 139. GlaxoSmithKline plc Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 140. GlaxoSmithKline plc Antibodies in Oncology Product
Table 141. GlaxoSmithKline plc Recent Development
Table 142. Biogen Idec Inc. Company Details
Table 143. Biogen Idec Inc. Business Overview
Table 144. Biogen Idec Inc. Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 145. Biogen Idec Inc. Antibodies in Oncology Product
Table 146. Biogen Idec Inc. Recent Development
Table 147. Bristol Myers Squibb Co. Company Details
Table 148. Bristol Myers Squibb Co. Business Overview
Table 149. Bristol Myers Squibb Co. Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 150. Bristol Myers Squibb Co. Antibodies in Oncology Product
Table 151. Bristol Myers Squibb Co. Recent Development
Table 152. AstraZeneca plc. Company Details
Table 153. AstraZeneca plc. Business Overview
Table 154. AstraZeneca plc. Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 155. AstraZeneca plc. Antibodies in Oncology Product
Table 156. AstraZeneca plc. Recent Development
Table 157. Celltrion Company Details
Table 158. Celltrion Business Overview
Table 159. Celltrion Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 160. Celltrion Antibodies in Oncology Product
Table 161. Celltrion Recent Development
Table 162. 3SBIO Company Details
Table 163. 3SBIO Business Overview
Table 164. 3SBIO Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 165. 3SBIO Antibodies in Oncology Product
Table 166. 3SBIO Recent Development
Table 167. Celgen Biopharma Company Details
Table 168. Celgen Biopharma Business Overview
Table 169. Celgen Biopharma Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 170. Celgen Biopharma Antibodies in Oncology Product
Table 171. Celgen Biopharma Recent Development
Table 172. Dr Reddy’s Company Details
Table 173. Dr Reddy’s Business Overview
Table 174. Dr Reddy’s Revenue in Antibodies in Oncology Business (2016-2021) (US$ Million)
Table 175. Dr Reddy’s Antibodies in Oncology Product
Table 176. Dr Reddy’s Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibodies in Oncology Market Share by Type: 2020 & 2027
Figure 2. Murine Antibodies Features
Figure 3. Chimeric and Humanised Antibodies Features
Figure 4. Fully Humanized Antibodies Features
Figure 5. Others Features
Figure 6. Global Antibodies in Oncology Market Share by Application: 2020 & 2027
Figure 7. Hospitals Case Studies
Figure 8. Academic Institutes Case Studies
Figure 9. Clinics Case Studies
Figure 10. Antibodies in Oncology Report Years Considered
Figure 11. Global Antibodies in Oncology Market Share by Regions: 2016 VS 2021 VS 2027
Figure 12. Global Antibodies in Oncology Market Size YoY Growth 2016-2027 (US$ Million)
Figure 13. Global Antibodies in Oncology Market Share by Regions (2022-2027)
Figure 14. Global Antibodies in Oncology Market Share by Players in 2020
Figure 15. Global Top Antibodies in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibodies in Oncology as of 2020)
Figure 16. The Top 10 and 5 Players Market Share by Antibodies in Oncology Revenue in 2020
Figure 17. North America Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 18. U.S. Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 19. Canada Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 20. Europe Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 21. Germany Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 22. France Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 23. U.K. Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 24. Italy Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 25. Russia Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 26. Asia-Pacific Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 27. China Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 28. Japan Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 29. South Korea Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 30. India Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 31. Australia Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 32. Taiwan Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 33. Indonesia Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 34. Thailand Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 35. Malaysia Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 36. Philippines Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 37. Vietnam Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 38. Latin America Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 39. Mexico Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 40. Brazil Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 41. Argentina Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 42. Middle East & Africa Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 43. Turkey Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 44. Saudi Arabia Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 45. UAE Antibodies in Oncology Market Size YoY Growth (2016-2027) (US$ Million)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed